The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy
Clinical trial NCT07040813 · RECRUITING
Trial details
- NCT number
- NCT07040813
- Sponsor
- Oslo University Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-06
- Primary completion
- 2029-01-31
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.